EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of vitamin C on the reduction of opioid consumption for acute musculoskeletal pain: A double-blind randomized control pilot study

Raoul Daoust iD, Jean Paquet, David Williamson, Vérilibe Huard, Caroline Arbour, Jeffrey J Perry, Marcel Émond, Simon Berthelot, Patrick Archambault, Dominique Rouleau, Judy Morris, Alexis Cournoyer

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0316450 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Raoul Daoust und 11 weiteren Autor:innen. Beteiligte Einrichtung: Study Center in Emergency Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord-de-l'Île de-Montréal), Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Analgesics, Opioid, Ascorbic Acid, Musculoskeletal Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent evidence has shown that vitamin C has analgesic and opioid sparing properties in immediate postoperative context. However, this has never been studied for acute musculoskeletal (MSK) emergency department (ED) injuries. The aim of this pilot study is to evaluate the feasibility of conducting a randomized placebo-controlled study to determine the opioid sparing and analgesic effect of vitamin C compared to placebo, in acute MSK injured ED patients.

Methods

A double-blind randomized controlled trial (RCT) distributed in two arms, stratified for fractures, was performed in a tertiary care center, one group receiving 1 g of vitamin C twice a day for 14 days and another receiving placebo. Participants were ≥18 years of age, treated in ED for MSK injuries present for ≤2 weeks, and discharged with a standardized opioid prescription of 20 morphine 5 mg tablets (M5T) and, at the clinician discretion, 28 tablets of naproxen 500 mg. Participants completed a 14-day paper diary and were contacted by phone at 14 days, to document their analgesic use, vitamin C consumption, and pain intensity.

Results

Overall, 137 patients were screened; 44(32%) were excluded, 38(40.9%) refused, leaving 55(59.1%) participants, with a consent rate of 9.2/month. Mean age was 53 years (SD = 16) and 55% were men. Fourteen (25%) participants were lost to follow-up and 33(83%) patients complied with treatment. For per-protocol analysis, the median (IQR) M5T consumed was 6.5 (3.3–19.5) for the vitamin C and 9.0 (1.5–16.0) for placebo group. The median (IQR) naproxen 500 mg tablets consumed was 0 (0–9.8) for the vitamin C group and 20 (0–27) for the placebo arm.

Conclusion

This pilot study supports the feasibility of a larger RCT on the opioid sparing and analgesic properties of vitamin C for acute MSK injured ED patients. Strategies to reduce the refusal and lost to follow-up rates are discussed. Trial registration number NCT05555576 , ClinicalTrials.Gov PRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidAscorbic AcidMusculoskeletal PainHumansMaleFemalePilot ProjectsDouble-Blind MethodAdultMiddle AgedAcute PainMorphineAged

Substanzen

Analgesics, OpioidAscorbic AcidMorphine

Autor:innen und Institutionen

  • Study Center in Emergency Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord-de-l'Île de-Montréal), Montréal, Québec, Canada.
  • Département de Médecine Familiale et de Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada.
  • Centre de Recherche de l'Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord de-l'Île-de-Montréal), Montréal, Québec, Canada.
  • Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada.
  • Faculté des Sciences Infirmières, Université de Montréal, Montréal, Québec, Canada.
  • Department of Emergency Medicine, University of Ottawa, Ontario, Canada.

ORCID-Profile: Raoul Daoust

Zitieren

APA

Daoust, R., Paquet, J., Williamson, D., Huard, V., Arbour, C., Perry, J. J., Émond, M., Berthelot, S., Archambault, P., Rouleau, D., Morris, J., & Cournoyer, A. (2024). Impact of vitamin C on the reduction of opioid consumption for acute musculoskeletal pain: A double-blind randomized control pilot study. PLOS ONE. https://doi.org/10.1371/journal.pone.0316450

Vancouver

Daoust R, Paquet J, Williamson D, Huard V, Arbour C, Perry JJ, et al. Impact of vitamin C on the reduction of opioid consumption for acute musculoskeletal pain: A double-blind randomized control pilot study. PLOS ONE. 2024. doi:10.1371/journal.pone.0316450

BibTeX
@article{Daoust2024,
  author = {Daoust, Raoul and Paquet, Jean and Williamson, David and Huard, Vérilibe and Arbour, Caroline and Perry, Jeffrey J and Émond, Marcel and Berthelot, Simon and Archambault, Patrick and Rouleau, Dominique and Morris, Judy and Cournoyer, Alexis},
  title = {Impact of vitamin C on the reduction of opioid consumption for acute musculoskeletal pain: A double-blind randomized control pilot study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0316450}
}
Kostenlos starten →